If you made any changes in Pure these will be visible here soon.

Personal profile

Personal information

Sandra Ortega Ugalde, MSc. studied Pharmacy at the University of the Basque Country (Spain) and worked thereafter as a pharmacist in Ireland for two years. In 2013 she started the Master in Drug Discovery and Safety at the VU University, Amsterdam, where she graduated with specialization in Molecular Toxicology. In July 2015, Sandra was awarded with one of the personal NWO AIMMS STAR (scientific top training in antimicrobial research) grants in the field of antimicrobials. With this grant Sandra started in September 2015 with a PhD research in the Molecular Toxicology and Molecular Microbiology research groups at the VU University. Her research aims at novel strategies to target Mycobacterium tuberculosis drug resistance by identifying and inhibiting constitutive and stress-induced mycobacterial cytochromes P450s (P450s)  that are essential for the survival of the pathogen, avoiding off-target interaction with human P450s.

Ancillary activities

No ancillary activities

Ancillary activities are updated daily

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 1 Similar Profiles
Ferredoxins Medicine & Life Sciences
Mycobacterium tuberculosis Medicine & Life Sciences
Cytochrome P-450 Enzyme System Medicine & Life Sciences
Oxidation-Reduction Medicine & Life Sciences
Genome Medicine & Life Sciences
Electrons Medicine & Life Sciences
Microbial Viability Medicine & Life Sciences
Cytochromes c Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2018

Open Access
Ferredoxins
Mycobacterium tuberculosis
Cytochrome P-450 Enzyme System
Oxidation-Reduction
Genome
Open Access

Prizes

AIMMS NWO STAR grant antimicrobial research

S. Ortega Ugalde (Recipient), 2015

Prize: Prize / AwardAcademic